Hologic has been granted an Innovative Technology contract from Vizient for its CoolSeal advanced energy portfolio and JustRight 5mm stapler.

The contract follows recommendations from hospital experts on Vizient's customer-led councils, which assess products for their potential to enhance clinical care, patient safety, and healthcare worker safety.

Vizient contract services senior director Kelly Flaharty said: “Our provider-led council recommended the JustRight 5mm stapler and CoolSeal advanced energy portfolio for this contract based on the efficiencies they offer and their potential to make an incremental difference in healthcare.”

The Hologic’s CoolSeal suite is said to be the only advanced bipolar vessel sealing portfolio in the US indicated for use in pediatric surgery.

It features advanced bipolar radio frequency technology to deliver accurate power for fast, secure seals with minimal thermal spread.

According to Hologic, the CoolSeal vessel sealing portfolio offers practical solutions for a range of surgical procedures that benefit from minimal thermal footprint and smaller incisions.

Said to be the smallest laparoscopic stapling instrument globally, the JustRight 5mm stapler is claimed to offer surgeons significant advantages. Its smaller size allows for greater flexibility as it can fit into tighter spaces than the usual staplers.

Furthermore, compared to larger devices, the JustRight 5mm stapler also occupies a less visible field in the scope.

Hologic's surgical solutions president Brandon Schnittker said: “We are honoured to be recognised by Vizient’s team of experts with this Innovative Technology contract.

“This contract underscores Hologic’s commitment to innovation and enhancing patient care and allows us to expand the reach of our vessel sealing portfolio and laparoscopic stapling device to ensure more surgeons and patients can benefit from the technologies.”

Vizient's diverse customer base includes academic medical centres, pediatric facilities, community hospitals, integrated health delivery networks, and non-acute healthcare providers.

Earlier this year, Hologic obtained US Food and Drug Administration clearance for its new Genius Digital Diagnostics System with the Genius Cervical AI algorithm for cervical cancer screening.